nonprofit logo

Global Coalition For Adaptive Research Inc

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 821199380 ✦ Larkspur, CA ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Global Coalition For Adaptive Research Inc?

Global Coalition For Adaptive Research Inc, based in Larkspur, California, is a nonprofit organization dedicated to leading the development and ongoing management of clinical trial platforms. Their primary mission is to accelerate the discovery and development of cures for patients suffering from rare and deadly diseases, such as glioblastoma. The organization's unique platform, GBM Agile, enables testing of multiple therapies concurrently against a common control to determine if these treatments yield improved overall survival rates compared to standard treatments. With a team of 31 employees, Global Coalition For Adaptive Research Inc continues to make strides in advancing medical research and potentially saving lives.


Official website here: www.gcaresearch.org

What are the reviews and ratings of this charity?

Charity Navigator Rating: 96% (Four-Star out of Four Stars)

Global Coalition For Adaptive Research Inc has earned a notable Four-Star rating from Charity Navigator, reflecting a strong commitment to accountability and financial health. The charity's score is derived solely from its exemplary performance in these areas, indicating a well-structured organization with transparent operations. The high percentage of independent board members and strong financial oversight practices contribute to the charity's credibility.

Strengths of this organization include its impressive program expense ratio of 94.18%, suggesting that the vast majority of its funds directly support its mission. Additionally, the charity has established robust policies regarding conflicts of interest and whistleblower protections, further enhancing its operational integrity. The absence of any material diversion of assets underscores its sound financial management.

While the charity's strong ratings highlight its effectiveness, it is important for potential donors and stakeholders to consider the impact of its programs. However, there are no significant limitations mentioned in the data. Overall, Global Coalition For Adaptive Research Inc exemplifies financial responsibility and governance, making it a trustworthy choice for philanthropic contributions.


This AI summary has been generated from information found on Charity Navigator.

Is Global Coalition For Adaptive Research Inc legitimate?

Global Coalition For Adaptive Research Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Global Coalition For Adaptive Research Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $2,264,602
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,972,617

For more financial information, click here


Official website here: www.gcaresearch.org

What is the mission statement of Global Coalition For Adaptive Research Inc?

The Global Coalition For Adaptive Research Inc is dedicated to spearheading the creation and continuous management of clinical trial platforms. This mission drives the organization to expedite the discovery and development of cures for patients afflicted by rare and fatal diseases. The unique platform, GBM Agile, is designed as a long-term solution to test multiple therapies simultaneously against a common control. Its primary objective is to evaluate various investigational treatments for either newly diagnosed or recurrent glioblastoma. The ultimate goal is to determine if any of these study treatments produce superior overall survival rates when compared to standard treatments.


Official website here: www.gcaresearch.org

Who is the CEO of Global Coalition For Adaptive Research Inc?

Meredith Buxton is the Chief Executive Officer & President of Global Coalition For Adaptive Research Inc. The CEO's salary of Global Coalition For Adaptive Research Inc is $700,000 and their total compensation is $748,256.


Official website here: www.gcaresearch.org

What is the revenue of Global Coalition For Adaptive Research Inc?

Global Coalition For Adaptive Research Inc's revenue in 2022 was $35,373,148.


Official website here: www.gcaresearch.org

Who are the executives of Global Coalition For Adaptive Research Inc and what are their salaries?

The average compensation at Global Coalition For Adaptive Research Inc during 2022 was $136,684. There are 31 employees and 39 volunteers at Global Coalition For Adaptive Research Inc.


Here are 18 key members and their salaries (Global Coalition For Adaptive Research Inc's CEO's salary is $700,000 and their total compensation is $748,256):


Brian Alexander Md Mph (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Faramarz Yousefzadeh Jd Llm (Chairman Of The Board)
  • Compensation: $0
  • Related: $0
  • Other: $0
Gary Gordon Md Phd (Senior Medical Advisor And Director)
  • Compensation: $84,000
  • Related: $0
  • Other: $0
John Frishkopf Mms (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sujuan Ba Phd (Secretary (Thru Mid-Dec)/Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Timothy Cloughesy Md (Chief Medical Officer And Director)
  • Compensation: $120,000
  • Related: $0
  • Other: $0
Wk Alfred Yung Md (Investigator China-Chair, Agile & Director)
  • Compensation: $48,360
  • Related: $0
  • Other: $0
Webster Cavenee Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Matthew Viva (Assoc Director Legal/Secretary)
  • Compensation: $225,992
  • Related: $0
  • Other: $19,681
Meredith Buxton (Chief Executive Officer & President)
  • Compensation: $700,000
  • Related: $0
  • Other: $48,256
Rachael Coleman (Cfo/Coo)
  • Compensation: $351,567
  • Related: $0
  • Other: $4,635
Ashley Powell (Executive Director Of Trial Ops)
  • Compensation: $274,663
  • Related: $0
  • Other: $17,060
Robert Murray (Chief Business Officer)
  • Compensation: $359,326
  • Related: $0
  • Other: $11,062
Apoorva Nelli (Senior Clinical Scientist)
  • Compensation: $177,074
  • Related: $0
  • Other: $18,299
Rachel Rosenstein Sisson (Sr Director Of Administration)
  • Compensation: $172,500
  • Related: $0
  • Other: $14,174
Sarah Untch (Assoc Director Trial Ops)
  • Compensation: $195,011
  • Related: $0
  • Other: $25,961
Tracey Roberts (Assoc Director, Clinical Operations)
  • Compensation: $190,000
  • Related: $0
  • Other: $19,835
Adam Johnson (Sr Manager Clin Data Management)
  • Compensation: $140,563
  • Related: $0
  • Other: $25,083


Official website here: www.gcaresearch.org

Where can I find the form 990 for Global Coalition For Adaptive Research Inc?

Global Coalition For Adaptive Research Inc's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.gcaresearch.org

Learn more at the official website: www.gcaresearch.org

Mission Statement of Global Coalition For Adaptive Research Inc

The Global Coalition For Adaptive Research Inc, with its unique mission, is dedicated to spearheading the development and continuous management of clinical trial platforms. This nonprofit organization is committed to expediting the discovery and development of cures for patients afflicted by rare and fatal diseases.

More specifically, Global Coalition For Adaptive Research Inc focuses on creating innovative clinical trial environments that enable the simultaneous evaluation of multiple therapeutic options. One such platform, GBM Agile, is designed for the testing of various investigational treatments for either newly diagnosed or recurrent glioblastoma. With this approach, researchers can compare the efficacy of new treatments to standard treatments, potentially leading to improved overall survival rates for patients.

By leading the development and ongoing management of these clinical trial platforms, the Global Coalition For Adaptive Research Inc plays a pivotal role in the scientific community's efforts to find cures for rare and deadly diseases. Through their innovative approach, they offer hope to patients who may have exhausted all other treatment options.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Global Coalition For Adaptive Research Inc significantly impacts the landscape of clinical trials and treatments for patients with rare and deadly diseases. By spearheading initiatives like the GBM AGILE platform, they facilitate a unique environment for the simultaneous testing of multiple therapies against a common control. This approach enables researchers to efficiently compare investigational treatments for glioblastoma, a highly aggressive form of brain cancer, thereby accelerating the rate at which effective therapies can be identified.

Through this innovative methodology, the coalition not only enhances the potential for improved overall survival rates for patients but also streamlines the clinical trial process. By enabling a collaborative and adaptive framework, they optimize resource utilization and expedite the discovery of viable treatment options. This leads to a more rapid translation of research findings into actionable therapies, significantly impacting patient outcomes and advancing the field of medical research for difficult-to-treat conditions.




This information is meant to be a general summary of Global Coalition For Adaptive Research Inc. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$35,373,148 (2022)
Expenses
$24,083,323 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $483,944
  • Program Service Revenue: $34,345,933
  • Gross Receipts: $35,373,148

Assets and Liabilities:

  • Total Assets: $59,575,227
  • Total Liabilities: $21,752,254
  • Net Assets: $37,822,973

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

TRIAL REVENUE

Revenue

$34,345,933

Organization Details

Founding Year

2017

Principal Officer

Meredith Buxton

Main Address

700 LARKSPUR LANDING CIRCLE 199, LARKSPUR, CA, 949391754

NTEE Category

Code: H48 - Medical research

If you are a representative of Global Coalition For Adaptive Research Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.